BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8427773)

  • 1. DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.
    Karlsson M; Boeryd B; Carstensen J; Kågedal B; Bratel AT; Wingren S
    Br J Cancer; 1993 Jan; 67(1):134-8. PubMed ID: 8427773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.
    Muhonen T; Pyrhönen S; Laasonen A; Asko-Seljavaara S; Franssila K
    Br J Cancer; 1991 Oct; 64(4):749-52. PubMed ID: 1911224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy and S-phase fraction in primary melanomas and their regional metastases.
    Karlsson M; Boeryd B; Carstensen J; Kågedal B; Wingren S
    Melanoma Res; 1994 Feb; 4(1):47-51. PubMed ID: 8032217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas.
    Karlsson M; Boeryd B; Carstensen J; Kågedal B; Wingren S
    Br J Cancer; 1995 Jan; 71(1):177-81. PubMed ID: 7819036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the prognostic value of DNA flow cytometry in metastatic melanoma by combining ploidy and S-phase fraction.
    Muhonen T
    Melanoma Res; 1992 Nov; 2(4):247-52. PubMed ID: 1490112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.
    Muhonen T; Pyrhönen S; Laasonen A; Wasenius VM; Asko-Seljavaara S; Franssila K; Kangas L
    Br J Cancer; 1992 Sep; 66(3):528-32. PubMed ID: 1520590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
    Friberg LG; Norén H; Delle U
    Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.
    Stanton PD; Cooke TG; Oakes SJ; Winstanley J; Holt S; George WD; Murray GD
    Br J Cancer; 1992 Nov; 66(5):925-9. PubMed ID: 1419638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
    Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
    Porschen R; Remy U; Bevers G; Schauseil S; Hengels KJ; Borchard F
    Cancer; 1993 Jun; 71(12):3846-50. PubMed ID: 8508352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
    Winter K; Eidtmann H; Jonat W
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis.
    Coleman K; Baak JP; van Diest PJ; Curran B; Mullaney J; Fenton M; Leader M
    Hum Pathol; 1995 Jan; 26(1):99-105. PubMed ID: 7821923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
    Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J
    Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study of prognostic value of DNA ploidy and proliferative activity in neuroblastoma.
    Huddart SN; Muir KR; Parkes SE; Mann JR; Stevens MC; Raafat F; Smith K
    J Clin Pathol; 1993 Dec; 46(12):1101-4. PubMed ID: 8282832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.